HLNCF:OTCMKTS
Haleon PLC
US$4,95
arrow_upward
+1,21%(+0,059) 1D
16 ຕ.ລ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HLNCF...
Open
US$4,81
High
US$4,98
Low
US$4,81
Mkt. cap
44,27 ຕື້
Avg. vol.
10,03 ພັນ
Volume
17,69 ພັນ
52-wk high
US$5,75
52-wk low
US$4,15
Beta
-21,47
Shares outstanding
8,80 ຕື້
No. of employees
25 ພັນ
Open
US$4,81
High
US$4,98
Low
US$4,81
Mkt. cap
44,27 ຕື້
Avg. vol.
10,03 ພັນ
Volume
17,69 ພັນ
52-wk high
US$5,75
52-wk low
US$4,15
Beta
-21,47
Shares outstanding
8,80 ຕື້
No. of employees
25 ພັນ
News stories
From web sources and news partners
Business Wire
·
21 ນາທີກ່ອນ
Power Integrations Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
51 ນາທີກ່ອນ
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Seeking Alpha
·
57 ນາທີກ່ອນ
3 things to look out for on Monday
Yahoo Finance
·
36 ນາທີກ່ອນ
GreenPower Announces Receipt of Letter from NASDAQ
Profile
Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England. It is one of the largest consumer healthcare businesses in the world, with brands including Sensodyne toothpaste, Panadol and Advil painkillers, and Centrum vitamins. The company was projected to be a global leader in over the counter medicines with a 7.3 per cent market share in 2022.
Haleon was established on 18 July 2022 as a corporate spin-off from GSK. Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange. Wikipedia
About Haleon PLC